Showing results (1011-1020 of 6,669) with videos related to
Sort By:
Pageof 667
Annals of Hematology|October 28, 2014
Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomideI-Jun Lau, Dean Smith, Robin Aitchison, et al.Annals of Hematology|December 16, 2014
Comparison and evaluation of three screening tests of hereditary spherocytosis in Chinese patientsYi-feng Tao, Zeng-fu Deng, Lin Liao, et al.Annals of Hematology|December 30, 2014
Applicability of the EORTC/MSG criteria for IFD in clinical practiceH Rieger, D Lustig, S Barlow, et al.Annals of Hematology|December 5, 2014
Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registryM W M van der Poel, S Oerlemans, H C Schouten, et al.Annals of Hematology|November 21, 2014
Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantationEolia Brissot, Xavier Cahu, Thierry Guillaume, et al.Annals of Hematology|November 23, 2014
HMG-CoA reductase inhibitors as adjuvant treatment for hematologic malignancies: what is the current evidence?Bruno Bockorny, Constantin A DasanuAnnals of Hematology|September 21, 2014
Immune thrombocytopenia: epidemiological and clinical features of 216 patients in northwestern TurkeyAhmet Koylu, Gulsum Emel Pamuk, Mehmet Sevki Uyanik, et al.Annals of Hematology|January 15, 2020
MicroRNAs: pivotal regulators in acute myeloid leukemiaMingyu Li, Xianglun Cui, Hongzai GuanAnnals of Hematology|November 20, 2020
Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasmsKarlo Huenerbein, Parvis Sadjadian, Tatjana Becker, et al.Annals of Hematology|November 5, 2020
Outcome predictors after retransplantation in relapsed acute lymphoblastic leukemia: a multicenter, retrospective studyYasuo Mori, Kensuke Sasaki, Yoshikiyo Ito, et al.Pageof 667